Research ArticleClinical Investigations
Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human
Christophe Plisson, David Weinzimmer, Steen Jakobsen, Sridhar Natesan, Cristian Salinas, Shu-Fei Lin, David Labaree, Ming-Qiang Zheng, Nabeel Nabulsi, Tiago Reis Marques, Shitij Kapur, Eiji Kawanishi, Takeaki Saijo, Roger N. Gunn, Richard E. Carson and Eugenii A. Rabiner
Journal of Nuclear Medicine April 2014, 55 (4) 595-601; DOI: https://doi.org/10.2967/jnumed.113.131409
Christophe Plisson
1Imanova Ltd., Centre for Imaging Sciences, Hammersmith Hospital, London, United Kingdom
David Weinzimmer
2Yale University PET Center, Yale University School of Medicine, New Haven, Connecticut
Steen Jakobsen
3Aarhus PET Centre, Aarhus Sygehus, Nørrebrogade, Aarhus C Denmark
Sridhar Natesan
4Institute of Psychiatry, King’s College, London, United Kingdom
Cristian Salinas
1Imanova Ltd., Centre for Imaging Sciences, Hammersmith Hospital, London, United Kingdom
Shu-Fei Lin
2Yale University PET Center, Yale University School of Medicine, New Haven, Connecticut
David Labaree
2Yale University PET Center, Yale University School of Medicine, New Haven, Connecticut
Ming-Qiang Zheng
2Yale University PET Center, Yale University School of Medicine, New Haven, Connecticut
Nabeel Nabulsi
2Yale University PET Center, Yale University School of Medicine, New Haven, Connecticut
Tiago Reis Marques
4Institute of Psychiatry, King’s College, London, United Kingdom
Shitij Kapur
4Institute of Psychiatry, King’s College, London, United Kingdom
Eiji Kawanishi
5Medicinal Chemistry Research Laboratories I, Research Division, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan; and
Takeaki Saijo
6DMPK Laboratories, Research Division, Mitsubishi Tanabe Pharma Corporation, Chiba, Japan
Roger N. Gunn
1Imanova Ltd., Centre for Imaging Sciences, Hammersmith Hospital, London, United Kingdom
Richard E. Carson
2Yale University PET Center, Yale University School of Medicine, New Haven, Connecticut
Eugenii A. Rabiner
1Imanova Ltd., Centre for Imaging Sciences, Hammersmith Hospital, London, United Kingdom
5Medicinal Chemistry Research Laboratories I, Research Division, Mitsubishi Tanabe Pharma Corporation, Yokohama, Japan; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 4
April 1, 2014
Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human
Christophe Plisson, David Weinzimmer, Steen Jakobsen, Sridhar Natesan, Cristian Salinas, Shu-Fei Lin, David Labaree, Ming-Qiang Zheng, Nabeel Nabulsi, Tiago Reis Marques, Shitij Kapur, Eiji Kawanishi, Takeaki Saijo, Roger N. Gunn, Richard E. Carson, Eugenii A. Rabiner
Journal of Nuclear Medicine Apr 2014, 55 (4) 595-601; DOI: 10.2967/jnumed.113.131409
Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human
Christophe Plisson, David Weinzimmer, Steen Jakobsen, Sridhar Natesan, Cristian Salinas, Shu-Fei Lin, David Labaree, Ming-Qiang Zheng, Nabeel Nabulsi, Tiago Reis Marques, Shitij Kapur, Eiji Kawanishi, Takeaki Saijo, Roger N. Gunn, Richard E. Carson, Eugenii A. Rabiner
Journal of Nuclear Medicine Apr 2014, 55 (4) 595-601; DOI: 10.2967/jnumed.113.131409